Novartis: all 3,900 studies
Page 35 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)CompletedNCT00369837Phase 3
- To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 DiabetesCompletedNCT00368134Phase 3
- Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes MellitusCompletedNCT00367978Phase 4
- Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus FelodipineCompletedNCT00367939Phase 3
- Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer.CompletedNCT00367471Phase 1
- Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic DermatitisCompletedNCT00367393Phase 4
- Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)CompletedNCT00367315Phase 3
- Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT00367094Phase 3
- Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA).CompletedNCT00366938Phase 3
- Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive BladderCompletedNCT00366002Phase 4
- Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer PainTerminatedNCT00365820Phase 2/3
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus HydrochlorothiazideCompletedNCT00360178Phase 3
- Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly SubjectsCompletedNCT00354016Phase 3
- Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II HypertensionCompletedNCT00353912Phase 3
- Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 DiabetesCompletedNCT00351884Phase 3
- A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 DiabetesCompletedNCT00351832Phase 3
- A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 DiabetesCompletedNCT00351585Phase 3
- A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 DiabetesCompletedNCT00351546Phase 3
- A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 DiabetesCompletedNCT00351507Phase 3
- Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current MonotherapyCompletedNCT00351130Phase 4
- Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic DermatitisCompletedNCT00351052Phase 3
- Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II HypertensionCompletedNCT00350168Phase 3
- Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small BowelCompletedNCT00350155Phase 4
- Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation PatientsTerminatedNCT00348634Phase 4
- Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and CelecoxibCompletedNCT00348491Phase 4
- Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal EventsCompletedNCT00346242Phase 4
- Purified Rabies Vaccine for Human Use (Chick-embryo Cell)CompletedNCT00345319Phase 3
- Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential HypertensionCompletedNCT00344110Phase 3
- Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.CompletedNCT00343551Phase 3
- An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.CompletedNCT00343226Phase 4
- Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or OlderWithdrawnNCT00342940Phase 2
- Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)CompletedNCT00338936Phase 3
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerApproved for marketingNCT00338247
- Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast CancerCompletedNCT00334139Phase 4
- Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee SurgeryCompletedNCT00333567Phase 4
- Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in HypertensionCompletedNCT00333489Phase 4
- Evaluation of the Safety of Relaxin in PreeclampsiaSuspendedNCT00333307Phase 1
- A Study of Letrozole in the Treatment of Endometrial CancerCompletedNCT00333086Phase 2
- Letrozole in Metastatic Breast Cancer in Combination With ChemotherapyCompletedNCT00333047Phase 2/3
- Efficacy of Octreotide Treatment in Patients With Primary Inoperable ThymomaCompletedNCT00332969Phase 2
- Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast CancerCompletedNCT00332852Phase 3
- Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast CancerCompletedNCT00330317Phase 3
- Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or OlderCompletedNCT00329966Phase 2
- Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast CancerCompletedNCT00329940Phase 3
- Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly SubjectsCompletedNCT00329927Phase 2
- Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic CancerCompletedNCT00329368Phase 1
- 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe HypertensionCompletedNCT00327587Phase 3
- A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on MonotherapyCompletedNCT00327145Phase 3
- Long-Term Safety Study of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00325429Phase 3
- To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea MonotherapyCompletedNCT00325117Phase 3
- Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDSTerminatedNCT00324025Phase 2
- Persistence of Antibody Response to N. Meningitidis Group C in ChildrenCompletedNCT00316654Phase 4
- Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.CompletedNCT00316628Phase 2
- Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.CompletedNCT00316615Phase 2
- Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant RecipientsCompletedNCT00312143Phase 4
- A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetesCompletedNCT00312130Phase 3
- Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical PatientsCompletedNCT00311753Phase 3
- A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)CompletedNCT00311740Phase 3
- Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for AdultsCompletedNCT00311493Phase 4
- Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly SubjectsCompletedNCT00311480Phase 2
- Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy ChildrenCompletedNCT00311441Phase 4
- Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 MonthsCompletedNCT00311428Phase 4
- Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy ChildrenCompletedNCT00311415Phase 3
- SPP100 Dose Finding Study in JapanCompletedNCT00311012Phase 2
- Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC VaccineCompletedNCT00310713Phase 4
- Kinetics of B Cell Response in Infants Menjugate VaccinationCompletedNCT00310700Phase 4
- Persistence of Immune Response After Vaccination With MCCCompletedNCT00310687Phase 4
- Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of AgeCompletedNCT00310674Phase 3
- Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)CompletedNCT00310648Phase 3
- Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of AgeCompletedNCT00310635Phase 4
- Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOSCompletedNCT00308425Phase 3
- Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01)CompletedNCT00308269Phase 1
- Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's DiseaseCompletedNCT00305903Phase 4
- A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic MelanomaCompletedNCT00304525Phase 1/2
- Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current MonotherapyCompletedNCT00304226Phase 4
- Safety of TKI258 in Advanced/Metastatic Melanoma SubjectsCompletedNCT00303251Phase 1/2
- Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid LeukemiaNo longer availableNCT00302016
- Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity DisorderCompletedNCT00301236Phase 3
- A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild HyperglycemiaCompletedNCT00300287Phase 3
- SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal DysfunctionCompletedNCT00299832Phase 3
- SPP100 (Aliskiren) Regimen in Patients With Severe HypertensionCompletedNCT00299806Phase 3
- Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy AdolescentsCompletedNCT00297817Phase 2
- A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of AmlodipineCompletedNCT00294710Phase 3
- A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart FailureCompletedNCT00294086Phase 2
- Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular DegenerationCompletedNCT00288561Phase 2
- Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and SteroidsCompletedNCT00284947Phase 4
- MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C PositiveTerminatedNCT00284921Phase 3
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With HypertensionCompletedNCT00280540Phase 4
- Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid LeukemiaTerminatedNCT00279773Phase 1
- The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and DyspepsiaWithdrawnNCT00277550Phase 4
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With HypertensionCompletedNCT00277472Phase 4
- Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial SeizuresCompletedNCT00275925Phase 4
- Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial SeizuresCompletedNCT00275912Phase 4
- Patupilone Activity in Advanced/Metastatic Hepatocellular CarcinomaCompletedNCT00273312Phase 2
- Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe HypertensionCompletedNCT00273299Phase 3
- Efficacy and Safety of LumiracoxibCompletedNCT00267215Phase 3
- Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled HypertensionCompletedNCT00267176Phase 4
- Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate TherapyCompletedNCT00264160Phase 2/3
- Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal CancerCompletedNCT00262990Phase 3
- Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate HypertensionCompletedNCT00262236Phase 3